Rightslink® by Copyright Clearance Center

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Author:

Victoria Furer,Tali Eviatar,Devy Zisman,Hagit Peleg,Daphna Paran,David Levartovsky,Michael Zisapel,Ofir Elalouf,Ilana Kaufman,Roni Meidan,Adi Broyde,Ari Polachek,Jonathan Wollman,Ira Litinsky,Katya Meridor,Hila Nochomovitz,Adi Silberman et al.

Publication:

Annals of Rheumatic Diseases

Publisher:

Elsevier

Date:

October 2021

Copyright © 2021 © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing this content.

I would like to...This drop down menu contains the options the publisher has agreed to permit for reuse of their copyrighted material. The publisher offers these types of use either directly through RightsLink or after approval by the publisher. Please reference the terms and conditions offered during the order process for a complete understanding of the use you select. Need more info?